Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of ϵ-aminocaproic acid and aprotinin

This publication has 24 references indexed in Scilit:

• The Systemic Inflammatory Response to Cardiac Surgery
  Anesthesiology, 2002
• Activation of Coagulation and Fibrinolysis during Coronary Surgery
  Anesthesiology, 2001
• Plasmin-induced expression of cytokines and tissue factor in human monocytes involves AP-1 and IKKβ-mediated NF-κB activation
  Blood, 2001
• Pharmacology and Biological Efficacy of a Recombinant, Humanized, Single-Chain Antibody C5 Complement Inhibitor in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardiopulmonary Bypass
  Circulation, 1999
• Cerebrovascular Cytokine Responses During Coronary Artery Bypass Surgery: Specific Production of Interleukin-8 and Its Attenuation by Hypothermic Cardiopulmonary Bypass
  Anesthesia & Analgesia, 1999
• Pharmacokinetics of ε-aminocaproic Acid in Patients Undergoing Aortocoronary Bypass Surgery
  Anesthesiology, 1999
• The Systemic Inflammatory Response to Cardiopulmonary Bypass
  Anesthesia & Analgesia, 1997
• SIRS—The Systemic Inflammatory Response Syndrome after cardiac operations
  The Annals of Thoracic Surgery, 1996
• Enhancement of Interleukin‐6 Production by Fibrinogen Degradation Product D in Human Peripheral Monocytes and Perfused Murine Liver
  Scandinavian Journal of Immunology, 1995
• Fibrin degradation product D‐dimer induces the synthesis and release of biologically active IL‐1β, IL‐6 and plasminogen activator inhibitors from monocytes in vitro
  British Journal of Haematology, 1994